{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:14:56Z","timestamp":1792282496451,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":863,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jpain.2020.12.001","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T11:24:20Z","timestamp":1609586660000},"page":"556-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey"],"prefix":"10.1016","volume":"22","author":[{"given":"Kevin F.","family":"Boehnke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel J.","family":"Gagnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Matallana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2020.12.001_bib0001","unstructured":"Administration USFaD. Warning Letters and Test Results for Cannabidiol-Related Products. 2019. Available at:https:\/\/www.fda.gov\/news-events\/public-health-focus\/warning-letters-and-test-results-cannabidiol-related-products Accessed April 15, 2020"},{"key":"10.1016\/j.jpain.2020.12.001_bib0002","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC202003030","article-title":"Fibromyalgia","volume":"172","author":"Bair","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2020.12.001_bib0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jpain.2020.12.001_bib0004","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpain.2020.12.001_bib0005","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2018.17722","article-title":"Pain management: Assembling a tool kit, building a life","volume":"320","author":"Boehnke","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2020.12.001_bib0006","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1377\/hlthaff.2018.05266","article-title":"Qualifying conditions of medical cannabis license holders in the United States","volume":"38","author":"Boehnke","year":"2019","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jpain.2020.12.001_bib0007","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jpain.2019.05.009","article-title":"Cannabis use preferences and decision-making among a cross-sectional cohort of medical cannabis patients with chronic pain","volume":"20","author":"Boehnke","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0008","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jpain.2019.01.010","article-title":"Pills to pot: Observational analyses of cannabis substitution among medical cannabis users with chronic pain","volume":"20","author":"Boehnke","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0009","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2017.11909","article-title":"Labeling accuracy of cannabidiol extracts sold online","volume":"318","author":"Bonn-Miller","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2020.12.001_bib0010","unstructured":"Brenan M. 14% of Americans Say They Use CBD Products. 2019. Available at: https:\/\/news.gallup.com\/poll\/263147\/americans-say-cbd-products.aspx Accessed April 21, 2020"},{"key":"10.1016\/j.jpain.2020.12.001_bib0011","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.jpain.2020.12.001_bib0012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/00325481.2019.1685298","article-title":"Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study","volume":"132","author":"Capano","year":"2019","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jpain.2020.12.001_bib0013","doi-asserted-by":"crossref","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0014","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: A case series","volume":"39","author":"Chagas","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jpain.2020.12.001_bib0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrrheum.2010.120","article-title":"Pain management: Fibromyalgia drugs are 'as good as it gets' in chronic pain","volume":"6","author":"Clauw","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0016","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: A clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2020.12.001_bib0017","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S2215-0366(16)30208-5","article-title":"Marijuana use and use disorders in adults in the USA, 2002\u201314: Analysis of annual cross-sectional surveys","volume":"3","author":"Compton","year":"2016","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.jpain.2020.12.001_bib0018","doi-asserted-by":"crossref","unstructured":"Corroon J, MacKay D, Dolphin W. Labeling of cannabidiol products: A public health perspective. Cannabis and Cannabinoid Research. 2020","DOI":"10.1089\/can.2019.0101"},{"key":"10.1016\/j.jpain.2020.12.001_bib0019","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/can.2018.0006","article-title":"A cross-sectional study of cannabidiol users","volume":"3","author":"Corroon","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpain.2020.12.001_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0269881119895536","article-title":"Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease","volume":"34","author":"de Faria","year":"2020","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0022","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0023","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Cannabidiol in Dravet syndrome study G. trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2020.12.001_bib0024","first-page":"1","article-title":"The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities","volume":"20","author":"Dixon","year":"2019","journal-title":"Curr Pharmaceut Biotechnol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0025","unstructured":"Foundation A. Patients Tell Us About CBD Use. 2019. Available at: http:\/\/blog.arthritis.org\/news\/patients-tell-us-cbd-use\/ Accessed June 5, 2020"},{"key":"10.1016\/j.jpain.2020.12.001_bib0026","doi-asserted-by":"crossref","DOI":"10.1080\/19390211.2020.1766634","article-title":"Content versus label claims in cannabidiol (CBD)-containing products obtained from commercial outlets in the state of Mississippi","author":"Gurley","year":"2020","journal-title":"J Diet Suppl"},{"key":"10.1016\/j.jpain.2020.12.001_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2018.01.022","article-title":"Trends in and correlates of medical marijuana use among adults in the United States","volume":"186","author":"Han","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2020.12.001_bib0028","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2474-13-74","article-title":"The German fibromyalgia consumer reports - a cross-sectional survey","volume":"13","author":"Hauser","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jpain.2020.12.001_bib0029","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","article-title":"Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome","volume":"11","author":"Hauser","year":"2010","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar4441","article-title":"Review of pharmacological therapies in fibromyalgia syndrome","volume":"16","author":"Hauser","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jpain.2020.12.001_bib0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamapsychiatry.2019.4157","article-title":"Leading the next CBD wave-safety and efficacy","volume":"77","author":"Hurd","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpain.2020.12.001_bib0032","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: A review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpain.2020.12.001_bib0033","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.jpain.2020.12.001_bib0035","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jpain.2020.12.001_bib0036","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Front Psychol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111886","article-title":"Myorelaxant effect of transdermal cannabidiol application in patients with TMD: A randomized, double-blind trial","volume":"8","author":"Nitecka-Buchta","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpain.2020.12.001_bib0038","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1097\/j.pain.0000000000001052","article-title":"Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis","volume":"158","author":"Philpott","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0039","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.forsciint.2018.10.019","article-title":"The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids","volume":"294","author":"Poklis","year":"2019","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jpain.2020.12.001_bib0040","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0041","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tips.2016.12.004","article-title":"Cannabidiol claims and misconceptions","volume":"38","author":"Russo","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jpain.2020.12.001_bib0042","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jpain.2020.12.001_bib0043","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/rheumatology\/kez303","article-title":"Top down or bottom up? An observational investigation of improvement in fibromyalgia symptoms following hip and knee replacement","volume":"59","author":"Schrepf","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jpain.2020.12.001_bib0044","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1097\/j.pain.0000000000001299","article-title":"Sensory sensitivity and symptom severity represent unique dimensions of chronic pain: a MAPP Research Network study","volume":"159","author":"Schrepf","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: A large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm J"},{"key":"10.1016\/j.jpain.2020.12.001_bib0046","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","article-title":"Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A systematic review and meta-analysis of controlled and observational studies","volume":"159","author":"Stockings","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0047","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jpain.2020.12.001_bib0048","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"van de Donk","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0049","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/PSY.0b013e31827264aa","article-title":"Functional somatic syndromes: Sensitivities and specificities of self-reports of physician diagnosis","volume":"74","author":"Warren","year":"2012","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpain.2020.12.001_bib0050","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1111\/j.1464-410X.2012.11422.x","article-title":"Prognostic factors for recent-onset interstitial cystitis\/painful bladder syndrome","volume":"111","author":"Warren","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.jpain.2020.12.001_bib0051","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.urology.2008.06.031","article-title":"Antecedent nonbladder syndromes in case-control study of interstitial cystitis\/painful bladder syndrome","volume":"73","author":"Warren","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.jpain.2020.12.001_bib0052","doi-asserted-by":"crossref","first-page":"e12135","DOI":"10.1111\/jabr.12135","article-title":"Phenotypic features of central sensitization","volume":"23","author":"Williams","year":"2018","journal-title":"J Appl Biobehav Res"},{"key":"10.1016\/j.jpain.2020.12.001_bib0053","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.rdc.2009.05.007","article-title":"Advances in the assessment of fibromyalgia","volume":"35","author":"Williams","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jpain.2020.12.001_bib0054","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/j.1532-2149.2012.00234.x","article-title":"Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia","volume":"17","author":"Wolfe","year":"2013","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2020.12.001_bib0056","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2174\/1389201020666191202111534","article-title":"The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities","volume":"21","author":"Xu","year":"2019","journal-title":"Curr Pharmaceut Biotechnol"},{"key":"10.1016\/j.jpain.2020.12.001_bib0057","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front Pharmacol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590020301176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590020301176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:04:23Z","timestamp":1761509063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590020301176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1526590020301176"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2020.12.001","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by United States Association for the Study of Pain, Inc.","name":"copyright","label":"Copyright"}]}}